Navigation Links
Susceptibility genes for cerebral infarction or hemorrhage in the Han in Hunan, China
Date:7/17/2013

Atherosclerosis is widely recognized as an independent risk factor for stroke, and its occurrence is closely related to lipid metabolism. numerous studies using transgenic and knockout animals have shown that scavenger receptor class B type I has a protective effect against atherosclerosis. Previous studies of scavenger receptor class B type I gene polymorphisms have focused on the exon 1 G4A polymorphism and the exon 8 C1050T polymorphism, and these polymorphic loci impact blood lipid levels and are involved in the dyslipidemia in diabetes patients. A recent study published in the Neural Regeneration Research (Vol. 8, No. 16, 2013) entitled "Susceptibility gene for stroke or cerebral infarction in the Han population in Hunan Province of China" has verified that A allele frequency was significantly lower than that in normal controls. The serum level of high-density lipoprotein cholesterol in patients with the scavenger receptor class B type I gene G4A GA + AA genotype was significantly higher, while the serum level of low-density lipoprotein cholesterol was significantly lower than that in patients with the GG genotype, in both the atherosclerotic cerebral infarction and cerebral hemorrhage groups. Authors believe that the G4A polymorphism of the scavenger receptor class B type I gene is a possible predisposing risk factor for atherosclerotic cerebral infarction, and that it has no association with cerebral hemorrhage in the Han population in Hunan province of China. The A allele is possibly associated with the metabolism of high-density and low-density lipoprotein cholesterol.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert

Page: 1

Related biology news :

1. UCI study reveals why Down syndrome boosts susceptibility to other conditions
2. Stress-resilience/susceptibility traced to neurons in reward circuit
3. New research helps predict susceptibility to Burkitt lymphoma
4. Gene variations linked to lung cancer susceptibility in Asian women
5. Mutations in autism susceptibility gene increase risk in boys
6. Exome sequencing of health condition extremes can reveal susceptibility genes
7. A new breast cancer susceptibility gene
8. Cigarette smoke impacts genes linked to health of heart and lungs
9. Insecticide causes changes in honeybee genes, research finds
10. Symptoms of Prader-Willi syndrome associated with interference in circadian, metabolic genes
11. Its all in the genes -- including the tracking device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2016)...  xG Technology, Inc. ("xG" or the "Company") (Nasdaq: ... for use in challenging operating environments, announced its results ... will hold a conference call to discuss these results ... (details below). Key Recent Accomplishments ... agreement to acquire Vislink Communication Systems. The purchase is ...
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... finalists in the World Technology Awards. uBiome is one of just six company ... all categories. , In addition to uBiome, companies nominated as finalists in this ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. (OTCQB: ... focused on developing and commercializing products to treat rare ... today that it will be hosting an Investor Webcast ... on the origins of innate defense regulators (IDRs) as ... of oral mucositis and the recently announced and published ...
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...
Breaking Biology Technology: